Literature DB >> 23192614

PTGDR polymorphisms and susceptibility to asthma: a meta-analysis.

Young Ho Lee1, Sung Jae Choi, Jong Dae Ji, Gwan Gyu Song.   

Abstract

The aim of this study was to explore whether prostaglandin D2 receptor (PTGDR) polymorphisms confer susceptibility to asthma. A meta-analysis was conducted on the associations between the PTGDR -549 C/T, -441 C/T, and -197 C/T polymorphisms and asthma using: (1) allele contrast, (2) the recessive model, (3) the dominant model, and (4) the additive model. Three polymorphism haplotypes were constructed in the order -549/-441/-179. Meta-analysis was performed on the haplotype CCC (high transcriptional activity) and of TCT (low transcriptional activity). A total of 13 separate comparative studies in 9 articles involving 7,155 patients with asthma and 7,285 control subjects were included in this meta-analysis. An association between asthma and the PTGDR -549 C/T polymorphism was found by allele contrast (OR = 1.133, 95 % CI = 1.004-1.279, P = 0.043). Ethnicity-specific meta-analysis showed an association between asthma and the PTGDR -549 C allele in Europeans (OR = 1.192, 95 % CI = 1.032-1.377, P = 0.017). Furthermore, stratifying subjects by age indicated an association between the PTGDR -549 C allele and asthma in adults (OR = 1.248, 95 % CI = 1.076-1.447, P = 0.003), but no association in children (OR = 0.933, 95 % CI = 0.756-1.154, P = 0.324). Analyses using the dominant and additive models showed the similar pattern as that observed for the PTGDR -549 C allele, that is, a significant association in Europeans and adults, but not in children. No association was found between asthma and the PTGDR -441 C/T or -197 C/T polymorphisms, and meta-analysis stratified by ethnicity and age also revealed no association between asthma and these polymorphisms. Furthermore, no association was found between asthma and the CCC and TCT haplotypes of PTGDR, and meta-analysis stratified by ethnicity and age revealed no association between asthma and the CCC and TCT PTGDR haplotypes. This meta-analysis demonstrates that the PTGDR -549 C/T polymorphism confers susceptibility to asthma in Europeans and adults. However, no association was found between the PTGDR 441 C/T and -197 C/T polymorphisms or the CCC and TCT haplotypes and asthma susceptibility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23192614     DOI: 10.1007/s11033-012-2280-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  27 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  The PTGDR gene is not associated with asthma in 3 ethnically diverse populations.

Authors:  Yuhjung J Tsai; Shweta Choudhry; Jennifer Kho; Kenneth Beckman; Hui-Ju Tsai; Daniel Navarro; Henry Matallana; Richard A Castro; Craig M Lilly; Sylvette Nazario; Jose R Rodriguez-Santana; Jesus Casal; Alfonso Torres; Jorge Salas; Rocio Chapela; H George Watson; Kelley Meade; Pedro C Avila; William Rodriguez-Cintron; Michael LeNoir; Esteban González Burchard
Journal:  J Allergy Clin Immunol       Date:  2006-09-26       Impact factor: 10.793

3.  Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility.

Authors:  Young Ho Lee; John B Harley; Swapan K Nath
Journal:  Eur J Hum Genet       Date:  2006-03       Impact factor: 4.246

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 5.  The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis.

Authors:  Y H Lee; Y H Rho; S J Choi; J D Ji; G G Song; S K Nath; J B Harley
Journal:  Rheumatology (Oxford)       Date:  2006-06-07       Impact factor: 7.580

Review 6.  GINA guidelines on asthma and beyond.

Authors:  J Bousquet; T J H Clark; S Hurd; N Khaltaev; C Lenfant; P O'byrne; A Sheffer
Journal:  Allergy       Date:  2007-02       Impact factor: 13.146

7.  The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men.

Authors:  C C Hardy; C Robinson; A E Tattersfield; S T Holgate
Journal:  N Engl J Med       Date:  1984-07-26       Impact factor: 91.245

8.  Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators.

Authors:  S E Wenzel; J Y Westcott; H R Smith; G L Larsen
Journal:  Am Rev Respir Dis       Date:  1989-02

Review 9.  Prostaglandin D₂ and T(H)2 inflammation in the pathogenesis of bronchial asthma.

Authors:  Masafumi Arima; Takeshi Fukuda
Journal:  Korean J Intern Med       Date:  2011-03-02       Impact factor: 2.884

10.  Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2.

Authors:  H Hirai; K Tanaka; O Yoshie; K Ogawa; K Kenmotsu; Y Takamori; M Ichimasa; K Sugamura; M Nakamura; S Takano; K Nagata
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.